ghk cu cancer risk Free Medical Journals clean-label Home | Regain Functional Treatment:3 Months

ghk cu cancer risk Free Medical Journals clean-label Home | Regain Functional Treatment:3 Months

Home | Regain Functional Medicine and Aesthetics

BENEFITS Modified structure — N-terminal acetylation plus C-terminal amidation vs base Selank Extended research size — 30mg suits multi-arm or longer-running study designs Comparative work — pairs directly against standard Selank, also stocked Tuftsin lineage — descends from a well-documented endogenous immunopeptide Verified identity — MS-confirmed against a third-party lab report you can check independently WHAT RESEARCHERS LOOK AT Stability profile of the acetylated/amidated form relative to unmodified Selank GABAergic and serotonergic signalling in preclinical anxiolytic models Neuroimmune interactions inherited from the tuftsin parent structure Comparative activity: modified vs unmodified Selank in parallel study arms Reconstitution handling and storage behaviour at the 30mg scale QUICK SPECS Form: Lyophilized peptide powder Net per vial: 30 mg Purity: ≥99% (HPLC verified) Identity: MS-verified (per COA) Storage: 2–8°C, protect from light and moisture Reconstitution: Use bacteriostatic water (sold separately) IDENTITY BASICS Compound: N-Acetyl Selank Amidate (NA-Selank Amidate) Parent compound: Selank, CAS 129954-34-3 — a synthetic tuftsin analog Parent sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (heptapeptide) Modifications: N-terminal acetylation + C-terminal amidation Also written as: NA-Selank Amidate, N-acetyl selank amidate WHY CHOOSE DURHAM PEPTIDES FOR N-ACETYL SELANK AMIDATE

clean-label

Treatment:3 Months

The NHS advises that taking up to 2 mg (2000 micrograms) per day of vitamin B12 in supplements is unlikely to cause harm